Generics Industry News Search
 |
|
|
|
|
|
|
October 2014 News Archive |
|
|
| |
|
Par Pharmaceutical today announced that it has begun shipping all four strengths of Amlodipine and Valsartan tablets, the generic version of Novartis' Exforge...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI Laboratories today announced it has acquired two previously marketed ophthalmic drug products...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Health Canada has banned the import of all drugs and drug ingredients made by two Apotex factories...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus announced that earlier today it sued Actavis for infringement of three patents...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the U.S. launch of its Lamivudine and Zidovudine tablets USP, 150 mg/300 mg, which is the generic version of Viiv's Combivir...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
UPSTO has granted MonoSol Rx's petition for inter partes review (IPR) of all claims of US Patent No. 7,579,019 ("the '019 patent") and has instituted the IPR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amgen today announced its Phase 3 study evaluating efficacy and safety
of biosimilar candidate ABP 501 compared with Humira (Adalimumab) in
patients with moderate-to-severe plaque psoriasis met its primary
endpoint...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Bristol-Myers Squibb has successfully resolved all outstanding U.S. patent litigation relating to Efavirenz, an active ingredient contained in our Sustiva (Efavirenz) and Atripla (Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate) products...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
India's pharm majors Dr Reddy's and Sun Pharm are among 14 drug makers which are being probed by the US Congress over price escalation of generic drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sucampo today announced that Sucampo, R-Tech Ueno (RTU), Takeda Pharmaceutical Company (Takeda) and certain affiliates of Takeda have entered into a settlement and license agreement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Germany's Stada plans to bring a copy of Eli Lilly's Forteo osteoporosis treatment to market, its chief executive said, as the generic drugmaker moves further into the sale of cheaper alternatives for costly biotech drugs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharmaceutical major Pfizer has received a patent for its anti-fungal drug Voriconazole, which it is selling in US under the brand name Vfend, overcoming opposition from Ranbaxy Labs and Natco Pharma...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Supernus Pharmaceuticals today announced that on October 13, 2014, the company received a Paragraph IV Notice Letter from Zydus Pharmaceuticals advising Supernus of the filing by Zydus of an ANDA seeking approval for...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mission Pharmacal Company today announced that the U.S. District Court for the Western District of Texas has issued a consent judgment confirming the validity of its dual-iron patent...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Breckenridge Pharmaceutical announces the immediate launch of Mefenamic acid 250mg capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Ministry of Health has opted for five medical firms for the production of Sovaldi (Sofosbuvir), the US-made Hepatitis C tablets, without conducting a tender beforehand...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Supreme Court on Wednesday appeared closely divided as it weighed Teva's high-profile fight with generic drug manufacturers over patent protections for Copaxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The largest biotech IPO yet, when Danish firm Forward Pharma debuts its $200 million offering later this year, could be derailed by Forward's recent announcement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ireland-headquartered generics major Actavis confirmed that it has filed an ANDA with the US FDA seeking approval to market Methylphenidate for extended-release oral suspension...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that it has filed an ANDA with the U.S. FDA seeking approval to market Methylphenidate hydrochloride for extended-release oral suspension...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Noven Pharmaceuticals announced today that it has filed a lawsuit in the U.S. District Court of New Jersey against Actavis for infringement of certain Noven patents...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amgen today announced that it filed a lawsuit in the U.S. District Court of Delaware against Sanofi, Aventisub, formerly doing business as Aventis Pharmaceuticals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Medical charity Medecins Sans Frontieres on Saturday accused the United States of ratcheting up pressure on India's new government to relax strict patent conditions which have made the country the "world's pharmacy"...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Basel-headquartered Novartis Pharmaceuticals dragged city-based Dr Reddy's Laboratories to the US court over alleged patent infringement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Another drugmaker is having to recall Metoprolol succinate extended release tablets, a generic for AstraZeneca hypertension drug Toprol XL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Natco Pharm's marketing partner in US, Breckenridge Pharmaceutical has received a tentative approval from the US health regulator for its generic Armodafinil tablets used for improving wakefulness in adults...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
CANDA NK-2 announced today that the company has moved to dismiss a patent infringement lawsuit, based on lack of personal jurisdictions over the defendants...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Over the last several months, there's been a flurry of activity surrounding the development of biosimilars...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The new head of the Canadian operations of AbbVie, the U.S. drug giant that recently scuppered its proposed merger with Shire, said Canada will not get more research and development work from big pharmaceutical companies until the country reforms its intellectual property rules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The legal tug-of-war between biotech giant Celgene and Natco Pharma, the generic drugmaker challenging certain Revlimid patents, may have seen some gains during Friday's hearing but now key invalidity issues have been decided yet, said Geoffrey Porges, a biotech analyst at Sanford Bernstein...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that the US Court of Appeals for the Federal Circuit has upheld a lower court ruling...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer announced today that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Medicines Company announced the U.S. District Court for the Northern District of Illinois in The Medicines Company v. Mylan entered judgment in favor of The Medicines Company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy might lose a key six-month exclusivity period for the generic version of Nexium - a blockbuster drug from AstraZeneca - if it fails to get regulatory clearance for the US market by the end of November...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr Reddy's Laboratories today said it has launched a generic version of Wyeth's Rapamune tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett today announced that it has received approval from FDA for its ANDA for Letrozole tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Cipla has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Deal-hungry Perrigo is looking for more seats at the over-the-counter table, and the drugmaker may soon get its wish...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical is optimistic the U.S. Supreme Court will decide in its favour regarding patent protection for Copaxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
TWi Pharmaceuticals announced that it has received final approval from the U.S. FDA on its ANDA for Donepezil hydrochloride tablets USP...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan announced the U.S. launch of its Nevirapine extended-release tablets, 400 mg, which is the generic version of Boehringer Ingelheim's Viramune XR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Efforts to end the long and bitter patent tussle between domestic pharm company Cipla and multinational Roche over a lung cancer drug have come to a naught...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Heritage announced the immediate availability of sterile Rifampin for injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
